Holocene Advisors, LP Abb Vie Inc. Transaction History

Holocene Advisors, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $7.42 Million - $8.67 Million	-47,967 Reduced 3.86%	1,195,042 $205 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $66.7 Million - $76 Million	-417,484 Reduced 25.14%	1,243,009 $226 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $228 Million - $257 Million	1,660,493 New	1,660,493 $257 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $161 Million - $199 Million	-1,216,806 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $64 Million - $81 Million	-596,047 Reduced 32.88%	1,216,806 $165 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $77.6 Million - $88.1 Million	729,682 Added 67.37%	1,812,853 $196 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $20.5 Million - $22.9 Million	195,231 Added 21.99%	1,083,171 $122 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $36.3 Million - $39.9 Million	-354,514 Reduced 28.53%	887,940 $96.1 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $12.8 Million - $17.2 Million	158,628 Added 14.64%	1,242,454 $133 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $40.1 Million - $47 Million	466,355 Added 75.53%	1,083,826 $94.9 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $45.3 Million - $60.6 Million	617,471 New	617,471 $60.6 Million

3,855

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.